Matthew Harrison
Stock Analyst at Morgan Stanley
(4.2)
Main Sectors:
Top Industries:
81 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ARGX argenx | Maintains: Overweight | 766 1040 | 800 | 30% | 26 | Oct 1, 2025 | |
DNLI Denali Therapeutics | Maintains: Overweight | 33 30 | 15.42 | 94.55% | 13 | Aug 18, 2025 | |
INSM Insmed | Downgrades: Equal-Weight | 112 126 | 157.16 | -19.83% | 19 | Aug 13, 2025 | |
LEGN Legend Biotech | Maintains: Overweight | 81 83 | 32.06 | 158.89% | 13 | Aug 12, 2025 | |
IOBT IO Biotech | Maintains: Overweight | 6 4 | n/a | n/a | 6 | Aug 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 460 439 | 403.12 | 8.9% | 38 | Aug 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 754 761 | 600 | 26.83% | 54 | Aug 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 146 144 | 159.88 | -9.93% | 50 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 15 20 | 22.64 | -11.66% | 38 | Jul 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 97 96 | 55.43 | 73.19% | 21 | Jul 22, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 130 135 | 112.69 | 19.8% | 36 | Apr 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 6 | 2.9 | 106.9% | 10 | Apr 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 39 32 | 28.49 | 12.32% | 25 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 5 | n/a | n/a | 10 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 15 5 | 1.62 | 208.64% | 5 | Mar 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 10 3 | 3.32 | -9.64% | 10 | Nov 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 8 11 | 23.23 | -52.65% | 9 | Jun 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 38 8 | 1.61 | 396.89% | 4 | Jun 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 7 | 3.92 | 78.57% | 18 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 34 34 | 23.39 | 45.36% | 14 | Apr 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 32 32 | 33.56 | -4.65% | 27 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 42 38 | n/a | n/a | 6 | Nov 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 14 4 | n/a | n/a | 6 | Sep 25, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 321 319 | n/a | n/a | 27 | Aug 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 21 19 | 6.32 | 200.63% | 3 | Aug 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 229 229 | n/a | n/a | 23 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Underweight | 60 60 | n/a | n/a | 30 | Jul 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 21 | n/a | n/a | 7 | Jul 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 46 | 30.9 | 48.87% | 1 | Apr 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 13 | n/a | n/a | 4 | Mar 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 2 1 | 1.16 | -13.79% | 3 | Mar 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 13 10 | 17.48 | -42.79% | 9 | Mar 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 27 8 | 9.22 | -13.23% | 9 | Feb 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 57 44 | 37.62 | 16.96% | 28 | Feb 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 10 | n/a | n/a | 5 | Jan 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 15 13 | 3.96 | 228.28% | 3 | Jan 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 140 80 | 17.75 | 350.7% | 4 | Jan 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 100 60 | 5.31 | 1029.94% | 4 | Jan 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 203 216 | 105.49 | 104.76% | 8 | Jan 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | 4.08 | 22.55% | 13 | Jan 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 7 5 | 1.98 | 152.53% | 6 | Jan 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 178 182 | 233.87 | -22.18% | 8 | Dec 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 9 | 15.06 | -40.24% | 13 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 30 40 | 46.1 | -13.23% | 6 | Nov 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 279 282 | 297.89 | -5.33% | 36 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 220 210 | 456.35 | -53.98% | 7 | Oct 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 736 621 | n/a | n/a | 7 | Sep 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 6 3 | n/a | n/a | 5 | May 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 55 52 | 27.36 | 90.06% | 5 | May 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 175 173 | 188.64 | -8.29% | 3 | Apr 6, 2022 |